Sodium-glucose cotransporter-2 inhibitor in risk of sepsis/septic shock among patients with type 2 diabetes mellitus-a retrospective analysis of nationwide medical claims data.
Naunyn Schmiedebergs Arch Pharmacol
; 397(3): 1623-1631, 2024 03.
Article
in En
| MEDLINE
| ID: mdl-37698621
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Shock, Septic
/
Diabetes Complications
/
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Naunyn Schmiedebergs Arch Pharmacol
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: